Investigators aim to assess if NSAIDs affect the quality of pleurodesis resulting from mechanical pleurodesis (open surgery or VATS) regarding : Primary outcome: Recurrence of pneumothorax in 6 monthes. (assessed by X ray after 2 weeks and 6 months or symptoms requiring X ray at any timing) Secondary outcome: â–ª Adjusted Length of stay ( from day zero surgery day to discharge ). â–ª Time of removal of the chest Tube .(relatively longer with air leak presence). â–ª Need of opioids (N-SAID may decrease the need of opioids) .
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Rate of recurrence of pneumothorax
Timeframe: With in 6 months or earlier with any new symptoms.